Sign Up Today and Learn More About Codiak Biosciences Stock
Invest in or calculate the value of your shares in Codiak Biosciences or other pre-IPO companies through EquityZen's platform.
About Codiak Biosciences Stock
Founded
2015
Headquarters
San Francisco, CA, US
Total Funding
174M
Industries
Science and Engineering, Health Care, Biotechnology
Codiak Biosciences is developing exosomes, natural vesicles that mediate inter-cellular communication, as both a powerful therapeutic modality and an advanced diagnostic system. Codiak is building a world-class team and has generated and acquired foundational intellectual property that will allow it to capitalize on the unique potential of exosome biology.
Codiak Biosciences Press Mentions
Stay in the know about the latest news on Codiak Biosciences
Codiak Presents New Preclinical Data for First-in-Class Exosome Therapeutic Candidates, exoIL-12 and exoSTING, Demonstrating Potent Anti-Tumor Activity
BusinessWire • Nov 08, 2019
Codiak Biosciences Lines up for $86 Million IPO
BioSpace • May 01, 2019
Exosomes Head to Wall Street As Codiak Biosciences Lines Up IPO
exomes • Apr 30, 2019
Codiak BioSciences Names Richard Brudnick Chief Business Officer and Head of Strategy
PR Newswire (press release) • Jun 04, 2018
Stem Cell Exosomes Market Report 2017: Identify Opportunities for Exosome Product Development - Research and ...
Business Wire (press release) • Dec 21, 2017
Investors in Codiak Biosciences
Discover investors in Codiak Biosciences stock and explore their portfolio companies
Codiak Biosciences Management
Leadership team at Codiak Biosciences
Chief Executive Officer
Doug Williams
Chief Business Officer
Richard Brudnick
Join now and verify your accreditation status to gain access to:
- Codiak Biosciences Current Valuation
- Codiak Biosciences Stock Price
- Codiak Biosciences Management
- Available deals in Codiak Biosciences and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Codiak Biosciences Cap Table and Funding History by Share Class and Liquidity Preferences
- Codiak Biosciences Revenue and Financials
- Codiak Biosciences Highlights
- Codiak Biosciences Business Model
- Codiak Biosciences Risk Factors
- Codiak Biosciences Research Report from SACRA Research
Trading Codiak Biosciences Stock
How to invest in Codiak Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Codiak Biosciences through EquityZen funds. These investments are made available by existing Codiak Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Codiak Biosciences stock?
Shareholders can sell their Codiak Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."